Annual accounts
Total Exemption Full accounts
31/12/2026Filing deadline
- Next accounts made up to
- 31/03/2026
- Last accounts made up to
- 31/03/2025
Reference data exactly as held at Companies House.
Every document filed at Companies House for this company.
Statement of capital following an allotment of shares on 2026-09-04
Confirmation statement made on 2026-07-28 with updates
Statement of capital following an allotment of shares on 2026-05-21
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Total Exemption Full accounts
31/12/2026Filing deadline
Confirms the registry record is up to date
The latest figures OBS MEDICAL LIMITED filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
2023: £-9.85M
Total Assets
2023: £228.07K
Cash in Bank
2023: £35.67K
Employees
2023: 7
Of the 3 measures with an earlier filing to compare against, 2 rose and 1 fell. Cash in bank moved furthest, up 101.52% on 2023. See the full financial analysis for OBS MEDICAL LIMITED.
The full financial record
Four ways through OBS MEDICAL LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 7 | 0 |
| 2023 | 7 | 0 |
| 2022 | 7 | 0 |
| 2021 | 7 | – |
Reported employee count was unchanged at 7 between 2021 and 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 05/06/2018–Present | 0 | |
| Director | 12/07/2011–01/02/2012 | 9 | |
| Director | 05/06/2018–Present | 2 | |
| Director | 01/03/2004–08/06/2006 | 2 | |
| Corporate Director | 21/11/2012–10/06/2016 | 0 | |
| Corporate Secretary | 30/01/2004–26/10/2015 | 109 | |
| Director | 07/10/2003–12/07/2011 | 47 | |
| Director | 25/04/2012–23/04/2015 | 17 | |
| Director | 17/04/2012–23/03/2016 | 20 | |
| Director | 23/04/2015–26/10/2015 | 40 | |
| Director | 04/01/2010–23/06/2010 | 28 | |
| Director | 28/06/2004–24/01/2006 | 11 | |
| Director | 19/05/2000–22/05/2006 | 41 | |
| Director | 19/05/2000–28/06/2004 | 14 | |
| Director | 24/01/2006–12/07/2011 | 13 | |
| Director | 19/02/2015–19/02/2015 | 19 | |
| Director | 19/01/2016–23/11/2017 | 19 | |
| Director | 28/11/2014–22/01/2017 | 12 | |
| Director | 17/04/2012–23/04/2015 | 16 | |
| Director | 19/05/2000–30/01/2004 | 1 | |
| Director | 07/10/2003–08/06/2006 | 9 | |
| Director | 08/06/2006–25/01/2011 | 11 | |
| Director | 19/05/2000–15/12/2009 | 8 | |
| Director | 19/10/2010–04/06/2011 | 8 | |
| Director | 01/10/2004–23/01/2006 | 2 | |
| Director | 28/04/2000–08/10/2003 | 8 | |
| Director | 23/11/2017–16/05/2018 | 3 | |
| Director | 05/06/2018–31/05/2020 | 3 | |
| Director | 22/07/2010–17/04/2012 | 3 | |
| Director | 23/04/2015–29/04/2017 | 4 | |
| Director | 05/01/2017–Present | 3 | |
| Director | 31/01/2007–16/07/2009 | 1 | |
| Secretary | 26/10/2015–23/03/2016 | 0 | |
| Secretary | 04/09/2017–31/05/2018 | 0 | |
| Secretary | 08/12/2015–07/06/2016 | 0 | |
| Director | 06/09/2007–13/03/2009 | 0 | |
| Director | 26/01/2004–11/12/2008 | 0 | |
| Nominee Secretary | 24/03/2000–19/05/2000 | 21 | |
| Nominee Director | 24/03/2000–28/04/2000 | 21 | |
| Secretary | 19/05/2000–30/01/2004 | 0 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 06/04/2016–Present | 2 |
Every document on the Companies House record, newest first.
Statement of capital following an allotment of shares on 2026-09-04
Confirmation statement made on 2026-07-28 with updates
Statement of capital following an allotment of shares on 2026-05-21
See when the next accounts and confirmation statement are due
84 UK companies are similar to OBS MEDICAL LIMITED, sharing the same company status (Active), the same industry sector and activity group (Other research and experimental development on natural sciences and engineering) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
2 Communications Road, Greenham Business Park, Newbury, Berkshire RG19 6AB
Allia Future Business Centre, Kings Hedges Road, Cambridge CB4 2HY
The Lexicon Second Floor, Mount Street, Manchester M2 5NT
Spitfire House 19 Falcon Court, Preston Farm Industrial Estate, Stockton-On-Tees TS18 3TU
76 Portland Place, London W1B 1NT
A short description of the company, written from its Companies House record.
OBS MEDICAL LIMITED is a private limited company registered in the United Kingdom, based in Unit 14 Cirencester Office Park, Tetbury Road, Cirencester GL7 6JJ. Companies House classifies its business as Other research and experimental development on natural sciences and engineering. It has been on the register for 26 years 6 months.
The register currently records it as active. Its 2024 accounts report net assets of £-9.85M and 7 employees.
Answered from this company's own registry record and filed figures.
Companies House records OBS MEDICAL LIMITED under one registered business activity: Other research and experimental development on natural sciences and engineering (72.19 - SIC 2007).
OBS MEDICAL LIMITED is recorded as active on the Companies House register, and has been on it since 24/03/2000.
The most recent accounts Okredo holds cover 2024 and report net assets of £-9.85M, total assets of £220.67K and cash in bank of £71.88K.
The most recent document on the record is dated 24/09/2026: Statement of capital following an allotment of shares on 2026-09-04, less than a month ago.
On the current registry record, accounts are due by 31/12/2026.
Companies House lists 40 officers (3 currently in post) and 1 person with significant control.